Aro Biotherapeutics

Philadelphia, PA · Founded 2018 · Privately Held (backing)

Developer of a protein drug platform designed to unlock the potential of genetic medicines. Aro Biotherapeutics is based in Philadelphia, PA and was founded in 2018. It was valued at $182 million at its later-stage round in Nov 2023, the last priced event on record. It has raised $132 million across 4 recorded rounds; the latest was a $24 million early-stage round in Dec 2022.

PMV mark · valuation
$181.5M
Oct 2026
Priced at
its later-stage round
Nov 2023
Total raised
$131.8M
Last round
Early Stage VC
Dec 2022
How much has Aro Biotherapeutics raised?
$131.8Macross 4 recorded rounds · Mar 2019 – Dec 2022

Most recently, Aro Biotherapeutics raised $24.0M in its Early Stage VC (Dec 2022).

Free account
More of Aro Biotherapeutics with a free account
  • ·Watch Aro Biotherapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Aro Biotherapeutics round by round

4 rounds
Dec 2022Early Stage VC$24.0MSEC filing▮
12 investors participated
Dec 2020Later Stage VC$90.3MSEC filing▮
14 investors participated
Dec 2019Early Stage VC$5.0MSEC filing▮
1 investors participated
Mar 2019Seed Round$3.5MSEC filing▮
3 investors participated

How much has Aro Biotherapeutics raised?

Aro Biotherapeutics has raised $132 million across 4 recorded rounds since 2019. The largest was a $90.3 million later-stage round in Dec 2020; the most recent was a $24 million early-stage round in Dec 2022.

Aro Biotherapeutics has filed 7 Form Ds with the SEC since 2019, most recently in Dec 2022 ($24 million sold to 12 investors).

Aro Biotherapeutics investors

10 investors are on record for Aro Biotherapeutics, including Johnson & Johnson Innovation - JLABS, Johnson & Johnson JJDC, Ridgeback Capital and Avego Management. The early-stage round in Dec 2022 drew 12 investors.

For fundraisers
Raising for a company like Aro Biotherapeutics?

10 investors have backed Aro Biotherapeutics.

See all 10 investors →

Frequently asked about Aro Biotherapeutics

How much has Aro Biotherapeutics raised?
Aro Biotherapeutics has raised $131.8M in total across 4 recorded funding rounds.
When was Aro Biotherapeutics's last funding round?
Aro Biotherapeutics's most recent recorded round was Early Stage VC in Dec 2022, raising $24.0M.